Acumen Pharmaceuticals, Inc. (ABOS) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est RA CAPITAL MANAGEMENT, L.P. avec 19,103,785 actions. Parmi les autres détenteurs notables OConnell Daniel Joseph et Zuga Matt.
Au cours des 12 derniers mois, les initiés ont effectué 57 transactions sur ABOS l'action — 16 achats (d'une valeur de $22.04M) et 36 ventes (d'une valeur de $409.61K). Les ventes d'initiés ont dépassé les achats durant cette période.
ABOS Participations des Initiés
Principal Actionnaire
RA CAPITAL MANAGEMENT, L.P.
19,103,785 actions
Achats (12 mois)
16
$22.04M valeur
Ventes (12 mois)
36
$409.61K valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Ra Capital Management, L.p. |
10 Percent Owner |
19,103,785 |
2026-03-18 |
|
| 2 |
Oconnell Daniel Joseph |
Chief Executive Officer |
883,964 |
2026-01-23 |
|
| 3 |
Zuga Matt |
CFO & Chief Business Officer |
306,611 |
2026-01-23 |
|
| 4 |
Siemers Eric |
Chief Medical Officer |
256,266 |
2026-01-23 |
|
| 5 |
Doherty James J. |
President and Cdo |
220,900 |
2026-01-21 |
|
| 6 |
Barton Russell |
Chief Operating Officer |
205,554 |
2026-01-23 |
|
| 7 |
Schacterle Amy |
Chief Regulatory Officer |
92,303 |
2026-01-21 |
|
| 8 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
71,048 |
2026-03-10 |
|
| 9 |
Golumbeski George |
Director |
50,000 |
2025-11-10 |
|
| 10 |
Sevigny Jeffrey |
Director |
25,000 |
2022-06-17 |
|
| 11 |
Shah Rajeev M. |
Director |
25,000 |
2022-06-21 |
|
| 12 |
Stalfort John A Iii |
Director |
19,500 |
2025-06-05 |
|
| 13 |
Fountain Nathan B |
Director |
19,050 |
2025-06-05 |
|
| 14 |
Eddleman Roy T |
Director |
15,000 |
2006-02-13 |
|
| 15 |
Stover Jack E |
Director |
15,000 |
2008-01-30 |
|
| 16 |
Kogod Dennis |
Director |
15,000 |
2008-01-30 |
|
| 17 |
Porter Derrell |
Director |
12,800 |
2025-06-05 |
|
| 18 |
Drapkin Kimberlee C |
Director |
12,800 |
2025-06-05 |
|
| 19 |
Stoppel Laura |
Director |
12,800 |
2025-06-05 |
|
| 20 |
Ives Jeffrey L. |
Director |
12,800 |
2025-06-05 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-03-16 |
Ra Capital Management, L.p. |
10 Percent Owner |
Attribution de RSU |
6,060,606 |
$3.30 |
$20M |
| 2026-03-06 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Exercice d'Options (Vente) |
2,090 |
$1.85 |
$3.87K |
| 2026-02-27 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Exercice d'Options (Vente) |
9,406 |
$1.85 |
$17.4K |
| 2026-01-28 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Exercice d'Options (Vente) |
2,671 |
$1.85 |
$4.94K |
| 2026-01-26 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Exercice d'Options (Vente) |
15,085 |
$1.85 |
$27.91K |
| 2026-01-22 |
Barton Russell |
Chief Operating Officer |
Vente Informative |
462 |
$1.84 |
$850.08 |
| 2026-01-21 |
Barton Russell |
Chief Operating Officer |
Vente Informative |
2,315 |
$1.81 |
$4.18K |
| 2026-01-22 |
Siemers Eric |
Chief Medical Officer |
Vente Informative |
895 |
$1.82 |
$1.63K |
| 2026-01-21 |
Siemers Eric |
Chief Medical Officer |
Vente Informative |
2,331 |
$1.80 |
$4.2K |
| 2026-01-22 |
Oconnell Daniel Joseph |
Chief Executive Officer |
Vente Informative |
2,689 |
$1.88 |
$5.07K |
| 2026-01-21 |
Oconnell Daniel Joseph |
Chief Executive Officer |
Vente Informative |
9,346 |
$1.81 |
$16.93K |
| 2026-01-22 |
Zuga Matt |
CFO & Chief Business Officer |
Vente Informative |
1,687 |
$1.86 |
$3.14K |
| 2026-01-21 |
Zuga Matt |
CFO & Chief Business Officer |
Vente Informative |
2,473 |
$1.81 |
$4.47K |
| 2026-01-23 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Vente Informative |
5,633 |
$1.90 |
$10.72K |
| 2026-01-22 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Vente Informative |
1,054 |
$1.84 |
$1.94K |
| 2026-01-21 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Vente Informative |
2,247 |
$1.81 |
$4.06K |
| 2026-01-16 |
Schacterle Amy |
Chief Regulatory Officer |
Attribution de RSU |
84,600 |
- |
- |
| 2026-01-16 |
Doherty James J. |
President and Cdo |
Attribution de RSU |
166,867 |
- |
- |
| 2026-01-16 |
Barton Russell |
Chief Operating Officer |
Attribution de RSU |
126,900 |
$1.89 |
$239.84K |
| 2026-01-16 |
Siemers Eric |
Chief Medical Officer |
Attribution de RSU |
148,700 |
$1.89 |
$281.04K |
| 2026-01-20 |
Oconnell Daniel Joseph |
Chief Executive Officer |
Attribution de RSU |
450,000 |
$1.86 |
$837K |
| 2026-01-16 |
Zuga Matt |
CFO & Chief Business Officer |
Attribution de RSU |
148,700 |
$1.89 |
$281.04K |
| 2026-01-16 |
Meisner Derek M |
Chief Legal Officer & Corp Sec |
Attribution de RSU |
148,700 |
$1.89 |
$281.04K |
| 2026-01-08 |
Barton Russell |
Chief Operating Officer |
Vente Informative |
3,530 |
$1.86 |
$6.56K |
| 2026-01-12 |
Oconnell Daniel Joseph |
Chief Executive Officer |
Vente Informative |
5,388 |
$1.73 |
$9.31K |
Les autres consultent aussi